10^th International Conference on
Virology, Influenza, and Infectious Diseases

Dr. Sagar M. Goyal is a Professor in the Veterinary Population Medicine Department, College of Veterinary Medicine at University of Minnesota in Saint Paul, USA. He is member of the Graduate Faculty in VetMed program. He has more than 50 years of experience in virology. His research interests in veterinary virology include disease pathogenesis, rapid diagnosis, strain variation, evaluation of antivirals and disinfectants, and prevention and control of viral infections in animals and poultry. His laboratory was responsible for the first isolation of avian metapneumovirus (aMPV) from Minnesota turkeys. A live, attenuated vaccine against APV was produced in his laboratory and was licensed by the USDA. In addition to his expertise on animal viruses, he is an expert in environmental virology. Areas of interest in environmental microbiology include drug resistant bacteria, human enteric viruses in food and water, fecal bacteria and phages as indicators of fecal pollution, and development of methods to detect small amounts of viruses from large quantities of food, water, and air.

Pathogenesis, rapid diagnosis, strain variation, evaluation of antivirals and disinfectants, and prevention and control of viral infections in animals and poultry.

Amgad Mohammed Rabie Hamed Fouda completed his MSc and Postgraduate studies in Pharmaceutical and Biomedical Sciences at the age of 30 years from the Faculty of Pharmacy, Mansoura University, Egypt. He is one of the most famous and reputed Egyptian and Arab pharmacists, researchers, and scientists. His new research focused on the synthesis, discovery, and development of new drugs and medicines for the most resistant and untreated human diseases. He is the head of pharmacists at the Dikernis General Hospital (Mansoura, Egypt), a premier governmental hospital in Egypt. He has published more than 25 papers in very reputable journals and serves as an Editorial Board Member of great repute.

Synthesis, Discovery, and Development of new drugs and Medicines.

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/Ph.D., master’s in clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program. He has also served as president of the WVU chapters for the American Association of Pharmaceutical Scientists, the Neurosurgery Interest group, and the Erlenmeyer Initiative Entrepreneur group. In addition, he has served as vice president for the graduate student neuroscience interest group, Nu Rho Psi Honor Society, and medical students for global health. He was an active member of the Gold Humanism Honor Society and Alpha Omega Alpha Honor Society. He is currently a member of the UF House Staff Council, Positive Culture Committee, Quality Improvement Committee, Board of Directors Alachua County Medical Society, and Accreditation Requirements Review Committee. He is married to Noelle Lucke-Wold and has two children. As a family, they enjoy running with their dogs, rock climbing and traveling. In his spare time, Brandon frequently runs half marathons and 10ks together with his wife. Brandon also enjoys reading, playing piano, discussing philosophy, and playing chess. He is currently a Pgy5 neurosurgery resident at the University of Florida with pursuing endovascular enfolded training and was awarded the Dempsey Cerebrovascular Research Fellowship.

Traumatic Brain Injury, Neurosurgical simulation, and Stroke.

Prof. Dr Muhammad Shoaib Khan is an educationist, philosopher, and economist. He is a key educationist. He has been teaching and researching in business, finance, and administration. He is a highly experienced professional. He has vast experience in teaching and in administration. He spent 13 years in the field of education and administrative positions. Dr Shoaib has offered his services to many institutions. He has taught in many institutions and remained in key administrative positions. He started his career at a private company and then chose to teach at the University of Sindh Larkana Campus, Noushoro Feroz Campus, as visiting faculty.

Economics, Mathematics and Artificial Intelligence

Pierre A. MORGON is the Founder of MRGN Advisors. He is Chairman of the board of Virometix and he is Non-Executive Director at the boards of Theradiag and of Eurocine Vaccines. He is also Regional Partner for Switzerland at Mérieux Development. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD, IMD and MCE executive programs.

Pharmaceutical, biological industry and in healthcare

Saso Cemerski, Senior Director at Cue Biopharma, leads the company’s Immuno-Oncology Discovery and Translational Immunology team. His focus is on early pipeline development, building preclinical packages for IO assets and developing translational biomarker strategies to test key hypotheses in the clinic. Prior to joining Cue Biopharma, Dr. Cemerski held positions at Xencor, BMS and most recently, MSD where he led the STING agonist programs and was a core- team member of the anti-LAG-3 program, both currently in the clinic. Dr. Cemerski did his postdoctoral training at Washington University in St Louis working on elucidating how immune synapses control T cell activation.

Oncology & Translational Immunology

Marek Malecki MD PhD is President of the Phoenix Foundation, San Francisco, CA, USA, Principal Investigator at the National Institutes of Health, Bethesda, MD, USA, and Visiting Professor at the University of Wisconsin. He earned the MD degree at the Medical Academy, Poznan followed by Residency/Fellowships in Molecular Medicine in Rigshospitalet, Copenhagen, Cancer Center, Vienna, and Cancer Center, Warsaw. He earned the PhD degree at the Polish Academy of Sciences, Warsaw followed by the postdoctoral fellowships in molecular biology at the Austrian Academy of Sciences, Salzburg, ETH, Zurich, Utrecht University, Utrecht, Cancer Center, Amsterdam, Biozentrum, Basel. Over the last 20 years, he held faculty positions in Oncology and Molecular Medicine at the leading teaching hospitals and medical universities in the USA including the UW, UCSD, and SDSU. There, he acquired solid experience in streamlining advances in genomics and proteomics into novel strategies of therapy, as well as in teaching medical students, residents, and fellows. During his career, he served as the president and CEO of the Phoenix Biomolecular and Foundation for Molecular Medicine. Since 1988 his research, as the Principal Investigator, was continuously funded by the grants from the National Science Foundation and the National Institutes of Health. He is the first or senior author on the peer-reviewed publications in the high impact journals, which are indexed on the PubMed. He is the inventor of the gene therapies, therapeutic vaccines, and regeneration of tissues, which are published at the USPTO and WIPO. He was elected to serve as the Editor in Chief in peer-reviewed, open-access journals in Science, Technology, and Medicine, as well as Editorial Board Member and Reviewer at many others. Close OCM Member Michael Vajdy Co-founder Principal and Chief Scientific Officer Mucosal Immunologist and Vaccinologist EpitoGenesis, Inc. USA Biography Research Interest OCM Member William B. Smith, MD, FACC President of New Orleans Center Professor of Medicine University of Tennessee Medical Center USA Biography Research Interest OCM Member Gregory J. Tobin VP/R&D, Chief Scientific Officer Biological Mimetics, Inc. USA Biography Research Interest OCM Member Carmen Alvarez-Dominguez Director of Genomics, Proteomics and Vaccines Institute Marqués de Valdecilla (IDIVAL) Spain Biography Research Interest

Gene therapies, therapeutic vaccines, and regeneration of tissues

Hoda saady mohamadin is an Associate Professor of Parasitology, South valley University, Egypt. Dr Saady received her doctorate in Parasitoogy from Egyptian University. Her recent publications includes: 1- Light and scanning electron microscopy on Serrasentis sagittifer, Linton, 1889 (Acanthocephal:Palaeacanthcephala : Rhadinorhynchidae ) infecting the common sea Bream in Egypt. J. Egypt. Soc. Parasitol 45 (1).21-26 2- Pelopscreadium aegyptense n. gen., n. sp. and Pelopscreadium spongiosum (Bray & Cribb, 1998) n. comb., (Digenea: Lepocreadiidae), each from disjunct populations of the Yellow boxfish, Ostracion cubicus Linnaeus (Ostraciidae). Zootaxa 4127 (3): 567–578.

Her research focuses of helminth parasitic in vertebrates in Egypt and the work focuses on two trends:- 1- Diversity and taxonomic studies of helminth parasites 2- Host parasite relationship.

Professor Zilberstein graduated as Ph.D. in microbiology at the Hebrew University of Jerusalem and continued his post doctorate studies at the US National Institutes of Health for infectious parasitic diseases. He joined the Technion Faculty of Biology and was its Dean. He is currently a member of the Technion Council and Board of Governors. In 2012 Professor Zilberstein was nominated executive director of Technion Pre University Education Center. To date, 19 M.Sc. and 14 Ph.D. students have graduated under Professor Zilbersteins' supervision. He has published 56 peer reviewed research papers and 12 reviews and book chapters. Over the years Professor Zilberstein has been awarded several prizes, the most recent was the 2014 Israel Sarov Prize from the Israel Society for Microbiology. Professor Zilberstein's expertise is cell biology and physiology of Leishmania parasites.

Membrane physiology and bioenergetics of the human pathogen Leishmania, Molecular mechanism of Leishmania differentiation, Proteomics and transcriptomics of Leishmania development,Amino acid transport in Leishmania parasites.

Dr. Glenn Simon Tillotson worked over 35 years in healthcare with almost 30 years in pharmaceuticals (R&D and Medical Affairs).Dr. Glenn Simon Tillotson has experience in drug research and development including pre-clinical studies, IND, NDA, MAA and product life cycle extension (sNDA). He had memberships of various societies. He has demonstrated success in range of product development, product launches and life cycle management strategies, harnessed innovative communication strategies both externally and internally, developed several medical affairs teams both internationally and nationally and shown resourcefulness in business development activities. He has written 200 papers (>150 papers on PubMed), 5 book chapters. He edited e-book on Clostridium difficile, published in September 2013 by Future Medicine, London, UK.

Clinical research, medical affairs, life cycle management

Marjorie Forgie Jaffet at present working as a doctor at NHS and she is the Master in International Health and she is the founder and director at Sparkles Kids Parties and Day Spa. Marjorie Forgie Jaffet had completed his masters in KIT Royal Tropical Institute in Amsterdam during the year 2017- 2018 and she had completed her bachelor of medicine and bachelor of surgery degree in university of Zimbabwe.

Rare Diseases

Rebecca Karimu Mtambo Holds Bachelor’s Degree in Public Health. She has also University Certificate in Global Health by university of Washington and Certificate in Strengthening Community Health Worker Programs by Harvard University. Rebecca is the National Drug resistance Tuberculosis mentor, trainer and national supervisor. She is the TB/HIV supervisor, Infection Prevention and Control Trainer of Trainer and the supervisor. Rebecca Karimu had worked in the busy DRTB referral centre in Malawi called Bwaila Hospital from 2015 to 2020. She is the Zonal Tuberculosis supervisor at the Quality Management Central West Zone comprising of four districts. She has attended over 12 national and 5 International conferences. One of her abstract titled “Adverse Effects of Linezolid among MultiDrug Resistance TB Patients in Malawi’ was published in international Journal of Clinical and Respiratory Diseases and Care: Open Access (HILARIS). Rebecca Karimu is the Public health activist and Influencer who specializes public health issues through her Public face book page, Interviews, supervisions, mentorships and dialogues.

Tuberculosis